K180288

Substantially Equivalent

QuickVue Influenza A+B

Applicant: Quidel Corporation
Product code: PSZ
Advisory panel: Microbiology
Date received: 2018-02-01
Decision date: 2018-02-13
Decision: Substantially Equivalent
Clearance type: Special
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.